Quick Compare & CRO Wizard
Location
You can select more than more location by keeping ctrl key pressed and clicking on locations
Pharm-Olam International
Pharm-Olam International (POI) is a Contract Research Organization (CRO) providing full-service clinical services for all phases of development for the Pharmaceutical, Biotechnology, and Medical Device Industries; as well as partnering with government, non-profit, institutional, and foundation agencies for clinical services
Company Contact:
Matt Delaney
Phone:+1 (713) 559-7970
Fax:+1 (713) 559-7901
Email:matt.delaney@pharm-olam.com
Website:http://www.pharm-olam.com
Address:450 N. Sam Houston Parkway E., Suite 250Houston, Texas 77060,
Matt DelaneyPhone:
+1 (713) 559-7970Fax:
+1 (713) 559-7901Email:
matt.delaney@pharm-olam.comWebsite:
http://www.pharm-olam.comAddress:
450 N. Sam Houston Parkway E., Suite 250Houston, Texas 77060,- World
- USA
- United Kingdom
- Ukraine
- Turkey
- Sweden
- Spain
- South America
- South Africa
- Slovak Republic
- Serbia
- Russia
- Romania
- Puerto Rico
- Portugal
- Poland
- Peru
- Norway
- Northern Europe
- North America
- Netherlands
- Mexico
- Macedonia, The Former Yugoslav Republic of
- Lithuania
- Latvia
- Kazakhstan
- Italy
- Israel
- Ireland
- India
- Hungary
- Guatemala
- Greece
- Germany
- Georgia
- France
- Finland
- Ex_US
- Ex_Europe
- Ex_Asia
- Europe
- Estonia
- Eastern Europe
- Denmark
- Czech Republic
- Costa Rica
- Colombia
- China
- Chile
- Canada
- Bulgaria
- Brazil
- Bosnia and Herzegovina
- Belgium
- Belarus
- Baltic States
- Austria
- Australia
- Asia
- Argentina
- Africa
CLINICAL DEVELOPMENT
Clinical Services Provided
Clinical TrainingData/IT/StatisticsBiostatisticsClinical Trial SimulationsData ManagementInformaticsEpidemiology/Health OutcomesMedical Monitoring/SafetyMedical WritingPost-MarketingProject ManagementProtocol DevelopmentRegulatory/Quality/SafetyElectronic sbmissionsPharmacovigilanceQuality AssuranceRegistries/Observational StudiesRegulatoryRisk AssesmentsSafety/PharmacovigilanceSite/Study/InvestigatorInvestigator EducationInvestigator RecruitmentPatient Recruitment/RetentionSite AuditSite ManagementSite SelectionStudy MonitoringStudy Supply Management
Clinical Study Type
Bioavailability/BioequivalenceBiomarkersImaging - Scintography & MRIPharmacogenomicsPharmacology/PathologyClinical PathologyClinical PharmacologyPhase 1 to 2Dose RangingFirst-in-Human StudiesPhase IPhase IIPhase IIaPhase 3Phase 4PK/PDSafety/TolerabilitySpecialized StudiesAge/GenderDrug Alcohol InteractionsDrug Drug InteractionsFood EffectGenotypingMicro dosingQT EvaluationRadio-Labeled StudiesSensory TestingSkin sensitization and irritation studiesSpecial PopulationsTaste/Sensory Evaluation
Formulations Administered
Therapeutic Area
Anesthesia/PainCancerCardiovascularCNSCritical CareEndocrine/MetabolismGastrointestinalGenitourinaryHematologyInfectious DiseasesInflammation/ImmuneMedical DevicesMens HealthMusculoskeletal DiseasesOphthalmologicalOrthopaedicsOsteologyPediatricsPlasma ProductsRespiratorySkin DiseasesVaccinesWomens HealthWound Care
CONSULTANT
REGULATORY
Formulation Category
Biopharmaceutical FormulationsCombination ProductsControlled SubstancesCytotoxic FormulationsDiagnosticsDPIGene DeliveryGenericsHigh Potency Drug FormulationsInhalationInjectableInjectable DepotMDIMedical DeviceNutraceuticalOpthalmicOralOTC formulationsPediatric FormulationsPEG/ProdrugsPrefilled SyringeTopicalTransdermal
SUPPLY CHAIN MANAGEMENT
Supply Chain Services
